First Quadrant’s Organon & Co OGN Stock Holding History

First Quadrant’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,657	Closed	-$120K	–	536
2021 Q3	$120K	Sell	3,657 -737	-17%	-$23.6K	0.01%	377
2021 Q2	$133K	Buy	+4,394	New	+$145K	0.02%	368

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Quadrant's OGN Position: Q4 2021 in Review

First Quadrant sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 3,657 shares — an estimated $120K sold.

First Quadrant first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $133K in Q2 2021. 908 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

First Quadrant reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
First Quadrant sold 3,657 Organon & Co shares in Q4 2021, an estimated $120K.
First Quadrant first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
First Quadrant's Organon & Co position peaked at $133K in Q2 2021.
908 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on First Quadrant's 13F filing for Q4 2021, filed 27 Jan 2022.